MedTrace Logo

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

NCT04717492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 584

Last updated 2025-01-31

Study results available
· View outcomes & findings →

Summary

The study is a prospective, observational study of patients admitted to the BLOCK COPD network hospitals with acute AMI and Chronic Obstructive Pulmonary Disease (COPD) to determine the prevalence of COPD in patients admitted to the hospital with an acute myocardial infarction (AMI) and to characterize the phenotypic expression and severity of their underlying lung disease. Patients with will be identified via the EMR. 571 participants will be enrolled.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

OTHER

Observational

Observational

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • University of Alabama at Birmingham

    collaborator OTHER

  • University of Minnesota

    lead OTHER

Principal Investigators

  • Mark Dransfield, MD · University of Alabama at Birmingham

  • John Connett, PhD · University of Minnesota

  • Stephen Lazarus, MD · University of California, San Francisco

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-28
Primary Completion
2022-05-18
Completion
2022-12-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04717492 on ClinicalTrials.gov